Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response

被引:21
作者
Kukkonen, Konsta [1 ,2 ]
Taavitsainen, Sinja [1 ,2 ]
Huhtala, Laura [1 ,2 ]
Uusi-Makela, Joonas [1 ,2 ]
Granberg, Kirsi J. [1 ,2 ]
Nykter, Matti [1 ,2 ]
Urbanucci, Alfonso [3 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Prostate Canc Res Ctr, Tampere 33520, Finland
[2] Tays Canc Ctr, Tampere 33520, Finland
[3] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, N-0424 Oslo, Norway
基金
芬兰科学院;
关键词
prostate cancer; epigenetics; chromatin; lineage commitment; lineage plasticity; chromatin-associated factors; castration resistant prostate cancer; drug resistance; androgen receptor signaling inhibitors; chromatin regulators alterations; METHYLTRANSFERASE METTL3 PROMOTES; ANDROGEN RECEPTOR CISTROME; BET BROMODOMAIN PROTEINS; HISTONE MODIFICATIONS; LINEAGE PLASTICITY; DNA METHYLATION; C-MYC; LUMINAL CELLS; GLOBAL LEVELS; STEM-CELLS;
D O I
10.3390/cancers13133325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Chromatin and epigenetic alterations in cancer are responsible for a wide range of transcriptional changes that link DNA mutations to tumor phenotype. In this review, we explore studies describing recurrent epigenetic alterations in prostate cancer and highlight changes that occur during prostate carcinogenesis and progression to lethal treatment-resistant disease. The dysregulation of chromatin and epigenetics has been defined as the overarching cancer hallmark. By disrupting transcriptional regulation in normal cells and mediating tumor progression by promoting cancer cell plasticity, this process has the ability to mediate all defined hallmarks of cancer. In this review, we collect and assess evidence on the contribution of chromatin and epigenetic dysregulation in prostate cancer. We highlight important mechanisms leading to prostate carcinogenesis, the emergence of castration-resistance upon treatment with androgen deprivation therapy, and resistance to antiandrogens. We examine in particular the contribution of chromatin structure and epigenetics to cell lineage commitment, which is dysregulated during tumorigenesis, and cell plasticity, which is altered during tumor progression.
引用
收藏
页数:31
相关论文
共 256 条
  • [71] Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
    Friedlander, Terence W.
    Roy, Ritu
    Tomlins, Scott A.
    Ngo, Vy T.
    Kobayashi, Yasuko
    Azameera, Aruna
    Rubin, Mark A.
    Pienta, Kenneth J.
    Chinnaiyan, Arul
    Ittmann, Michael M.
    Ryan, Charles J.
    Paris, Pamela L.
    [J]. CANCER RESEARCH, 2012, 72 (03) : 616 - 625
  • [72] Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line
    Gal-Yam, Einav Nili
    Egger, Gerda
    Iniguez, Leo
    Holster, Heather
    Einarsson, Steingrimur
    Zhang, Xinmin
    Lin, Joy C.
    Liang, Gangning
    Jones, Peter A.
    Tanay, Amos
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 12979 - 12984
  • [73] Towards a comprehensive catalogue of validated and target-linked human enhancers
    Gasperini, Molly
    Tome, Jacob M.
    Shendure, Jay
    [J]. NATURE REVIEWS GENETICS, 2020, 21 (05) : 292 - 310
  • [74] Epigenetic modulations and lineage plasticity in advanced prostate cancer
    Ge, R.
    Wang, Z.
    Montironi, R.
    Jiang, Z.
    Cheng, M.
    Santoni, M.
    Huang, K.
    Massari, F.
    Lu, X.
    Cimadamore, A.
    Lopez-Beltran, A.
    Cheng, L.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (04) : 470 - 479
  • [75] Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
    Gerhauser, Clarissa
    Favero, Francesco
    Risch, Thomas
    Simon, Ronald
    Feuerbach, Lars
    Assenov, Yassen
    Heckmann, Doreen
    Sidiropoulos, Nikos
    Waszak, Sebastian M.
    Huebschmann, Daniel
    Urbanucci, Alfonso
    Girma, Etsehiwot G.
    Kuryshev, Vladimir
    Klimczak, Leszek J.
    Saini, Natalie
    Stuetz, Adrian M.
    Weichenhan, Dieter
    Boettcher, Lisa-Marie
    Toth, Reka
    Hendriksen, Josephine D.
    Koop, Christina
    Lutsik, Pavlo
    Matzk, Soeren
    Warnatz, Hans-Joerg
    Amstislayskiy, Vyacheslav
    Feuerstein, Clarissa
    Raeder, Benjamin
    Bogatyrova, Olga
    Schmitz, Eva-Maria
    Hube-Magg, Claudia
    Kluth, Martina
    Huland, Hartwig
    Graefen, Markus
    Lawerenz, Chris
    Henry, Gervaise H.
    Yamaguchi, Takafumi N.
    Malewska, Alicia
    Meiners, Jan
    Schilling, Daniela
    Reisinger, Eva
    Eils, Roland
    Schlesner, Matthias
    Strand, Douglas W.
    Bristow, Robert G.
    Boutros, Paul C.
    von Kalle, Christof
    Gordenin, Dmitry
    Sueltmann, Holger
    Brors, Benedikt
    Sauter, Guido
    [J]. CANCER CELL, 2018, 34 (06) : 996 - +
  • [76] BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer
    Giles, Katherine A.
    Gould, Cathryn M.
    Achinger-Kawecka, Joanna
    Page, Scott G.
    Kafer, Georgia R.
    Rogers, Samuel
    Luu, Phuc-Loi
    Cesare, Anthony J.
    Clark, Susan J.
    Taberlay, Phillippa C.
    [J]. CLINICAL EPIGENETICS, 2021, 13 (01)
  • [77] The Metabolic Landscape of Prostate Cancer
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Loda, Massimo
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (01): : 28 - 36
  • [78] Identification of a Cell of Origin for Human Prostate Cancer
    Goldstein, Andrew S.
    Huang, Jiaoti
    Guo, Changyong
    Garraway, Isla P.
    Witte, Owen N.
    [J]. SCIENCE, 2010, 329 (5991) : 568 - 571
  • [79] The mutational landscape of lethal castration-resistant prostate cancer
    Grasso, Catherine S.
    Wu, Yi-Mi
    Robinson, Dan R.
    Cao, Xuhong
    Dhanasekaran, Saravana M.
    Khan, Amjad P.
    Quist, Michael J.
    Jing, Xiaojun
    Lonigro, Robert J.
    Brenner, J. Chad
    Asangani, Irfan A.
    Ateeq, Bushra
    Chun, Sang Y.
    Siddiqui, Javed
    Sam, Lee
    Anstett, Matt
    Mehra, Rohit
    Prensner, John R.
    Palanisamy, Nallasivam
    Ryslik, Gregory A.
    Vandin, Fabio
    Raphael, Benjamin J.
    Kunju, Lakshmi P.
    Rhodes, Daniel R.
    Pienta, Kenneth J.
    Chinnaiyan, Arul M.
    Tomlins, Scott A.
    [J]. NATURE, 2012, 487 (7406) : 239 - 243
  • [80] Grbesa I., 2021, SPOP MUTATION CONFER, DOI [10.1101/2021.04.20.440154, DOI 10.1101/2021.04.20.440154]